In addition to their origins as treatment for type 2 diabetes, GLP-1 receptor agonists like Ozempic and Wegovy are often most closely associated with obesity and weight loss. But did you know these ...

After nearly a century of disagreements over what, exactly, defines the condition, as well as a lack of research, PCOS is still poorly understood. The symptoms are so varied that any single drug would ...

Please provide your email address to receive an email when new articles are posted on . Low-dose birth control pills did not change the prevalence of metabolic syndrome among women with polycystic ...

Polycystic ovary syndrome is a very common hormone problem for women of childbearing age and a major cause of infertility. It affects about 1 in 10 U.S. women. Globally, PCOS cases among women of ...

For something that affects one in ten Australian women and AFAB people, Polycystic Ovary Syndrome (PCOS) is hardly spoken about. Which is why it's not that surprising that a staggering 70% of people ...

Ottawa, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The global polycystic ovary syndrome treatment market size was valued at USD 4.83 billion in 2024 and is predicted to hit around USD 9.12 billion by 2034, ...

Every morning, Jeni Gutke swallows 12 pills. In the evening, she takes 15 more, then another before bed. She also takes an injectable medication once weekly, and two other medications as needed. Gutke ...